Stock A289080 SV INVESTMENT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials SV Investment Corporation

Equities

A289080

KR7289080004

Investment Management & Fund Operators

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-29 pm EDT 		5-day change 1st Jan Change
2,065 KRW -1.90% Intraday chart for SV Investment Corporation +1.72% +0.24%
May. 13 MetisX Co., Ltd. announced that it has received $44 million in funding from a group of investors CI
Apr. 30 Avelos Therapeutics Inc. announced that it has received KRW 17 billion in funding from a group of investors CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023
Capitalization 1 113,122 237,956 238,754 196,966 127,495
Enterprise Value (EV) 1 100,668 230,115 230,867 189,649 123,565
P/E ratio 6.79 x -98.9 x 26.9 x 18.4 x 37 x
Yield 5.65% 0.67% 1.11% 1.62% 0.84%
Capitalization / Revenue 3.71 x 20.6 x 7.99 x 6.26 x 5.03 x
EV / Revenue 3.3 x 19.9 x 7.73 x 6.03 x 4.88 x
EV / EBITDA - - - - -
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book 0.95 x 4.44 x 3.94 x 2.85 x 1.81 x
Nbr of stocks (in thousands) 53,234 53,234 53,234 53,234 53,234
Reference price 2 2,125 4,470 4,485 3,700 2,395
Announcement Date 6/20/19 6/11/20 6/17/21 6/16/22 6/22/23
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 17,634 30,509 11,535 29,868 31,477 25,334
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 7,515 8,010 -2,408 10,899 13,823 4,540
Net income 1 6,149 7,991 -2,406 8,868 10,707 3,449
Net margin 34.87% 26.19% -20.86% 29.69% 34.02% 13.61%
EPS 2 136.0 312.8 -45.19 166.6 201.0 64.79
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - 120.0 30.00 50.00 60.00 20.00
Announcement Date 5/29/18 6/20/19 6/11/20 6/17/21 6/16/22 6/22/23
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 924 12,454 7,841 7,888 7,317 3,930
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) 29.1% 19.3% -4.26% 15.5% 16.5% 4.95%
ROA (Net income/ Total Assets) 19.6% 15.7% -3.77% 13.1% 13.9% 4.42%
Assets 1 31,409 50,780 63,847 67,521 76,818 78,115
Book Value Per Share 2 515.0 2,230 1,006 1,137 1,297 1,322
Cash Flow per Share 2 168.0 468.0 147.0 148.0 137.0 130.0
Capex 1 43.5 449 26.2 14.5 22.7 23.1
Capex / Sales 0.25% 1.47% 0.23% 0.05% 0.07% 0.09%
Announcement Date 5/29/18 6/20/19 6/11/20 6/17/21 6/16/22 6/22/23
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Venture Capital

1st Jan change Capi.
SV INVESTMENT CORPORATION Stock SV Investment Corporation
+0.24% 80.01M
HERCULES CAPITAL, INC. Stock Hercules Capital, Inc.
+17.22% 3.12B
UMBRA COMPANIES INC. Stock Umbra Companies Inc.
+12.82% 1.77B
HBM HEALTHCARE INVESTMENTS AG Stock HBM Healthcare Investments AG
+13.09% 1.58B
OCTOPUS TITAN VCT PLC Stock Octopus Titan VCT plc
-11.54% 1.21B
MOLTEN VENTURES PLC Stock Molten Ventures Plc
+23.02% 818M
CION INVESTMENT CORPORATION Stock CION Investment Corporation
+10.17% 671M
VERUSA HOLDING Stock Verusa Holding
+28.93% 552M
OCTOPUS APOLLO VCT PLC Stock Octopus Apollo VCT plc
-4.17% 506M
WOORI TECHNOLOGY INVESTMENT CO., LTD Stock Woori Technology Investment Co., Ltd
+33.23% 486M
Venture Capital
  1. Stock Market
  2. Equities
  3. A289080 Stock
  4. Financials SV Investment Corporation